⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13062482 | 1.00 | — | — | |
| SCHEMBL22720619 | 1.00 | AKR1B1 (0.41) | — | |
| SCHEMBL37362 | 1.00 | — | — | |
| SCHEMBL1198324 | 1.00 | — | — | |
| SCHEMBL574324 | 1.00 | — | — | |
| SCHEMBL477499 | 1.00 | — | — | |
| SCHEMBL6272445 | 1.00 | AKR1B1 (0.41) | — | |
| SCHEMBL22720618 | 1.00 | AKR1B1 (0.41) | — | |
| SCHEMBL4436039 | 0.97 | AKR1B1 (0.39) | — | |
| Charcoal, Activated SCHEMBL6447300 | 0.97 | AKR1B1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025064821-A2 | COMPOUNDS AND METHODS FOR INHIBITING LPA | IONIS PHARMACEUTICALS, INC. (US) | 2025-03-27 | — | — | WO | claimed |
| EP-3925948-B1 | INTERMEDIATE OF ERIBULIN, SYNTHESIS METHOD THEREFOR AND USE THEREOF | BEIJING TIENYI LUFU PHARMATECH CO LTD (CN) | 2024-08-07 | — | — | EP | claimed |
| US-20210386683-A1 | COMPOSITIONS AND METHODS RELATING TO RESVERATROL | WILMORE LABS, LLC | 2021-12-16 | — | — | US | claimed |
| US-20180021267-A1 | COMPOSITIONS AND METHODS RELATING TO RESVERATROL | WILMORE LABS LLC | 2018-01-25 | — | — | US | claimed |
| US-20150216982-A1 | COMPOSITIONS AND METHODS RELATING TO RESVERATROL | WILMORE LABS LLC | 2015-08-06 | — | — | US | claimed |
| US-20110130469-A1 | COMPOSITIONS AND METHODS RELATING TO RESVERATROL | WILMORE LABS L.L.C (US) | 2011-06-02 | — | — | US | claimed |
| US-20050228175-A1 | Production method of 2-deoxy-L-ribose compound | AJINOMOTO CO., INC. (JP) | 2005-10-13 | — | — | US | claimed |
| EP-1574515-A2 | Production method of 2-deoxy-L-ribose compound | Ajinomoto Co., Inc. (JP) | 2005-09-14 | — | — | EP | claimed |
| US-5659021-A | Chiral glycerol derivatives | THE BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS (US) | 1997-08-19 | — | — | US | claimed |
| US-5434266-A | Amidrazone derivatives | CORNELL RESEARCH FOUNDATION, INC. (US) | 1995-07-18 | — | — | US | claimed |
| US-4462993-A | REACTION WITH A SUGAR IN PRESENCE OF ACID CATALYST | BIOGAL GYOGYSZERGYAR (HU) | 1984-07-31 | — | — | US | claimed |
| US-12630595-B2 | Regulatory nucleic acid sequences | AskBio Inc. | 2026-05-19 | — | — | US | disclosed |
| US-12600969-B2 | Expression control using a regulatable intron | AskBio Inc. (US) | 2026-04-14 | — | — | US | disclosed |
| US-20260092272-A1 | Integration and Selection System | ANTIBODY ANALYTICS LIMITED (GB) | 2026-04-02 | — | — | US | disclosed |
| US-12590129-B2 | Liver-specific regulatory nucleic acid sequences | AskBio Inc. | 2026-03-31 | — | — | US | disclosed |
| US-4929723-A | Process for preparing 2-deoxynucleosides | ETHYL CORPORATION (US) | 1990-05-29 | — | — | US | disclosed |
| EP-0300765-A2 | Process for preparing 2-deoxynucleosides | ETHYL CORPORATION (US) | 1989-01-25 | — | — | EP | disclosed |
| US-4675390-A | HYPOTENSIVE, ANTITUMOR, ANTICOAGULANT | ELI LILLY AND COMPANY (US) | 1987-06-23 | — | — | US | disclosed |
| US-4675390-A | HYPOTENSIVE, ANTITUMOR, ANTICOAGULANT | ELI LILLY AND COMPANY (US) | 1987-06-23 | — | — | US | disclosed |
| US-4107435-A | Process for ω-amino-2-hydroxyalkyl derivatives of aminoglycoside antibiotics | PFIZER INC. (US) | 1978-08-15 | — | — | US | disclosed |